Etoricoxib 60 mg
- Generic
- Etoricoxib
- Manufacturer
- Bristol Pharmaceuticals Ltd.
- Drug class
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Price
৳6 per unit
Packs & prices
- per unit৳6
This is information only. Do not start, stop or switch medicines without a doctor's advice.
Warnings
Contraindications
- Hypersensitivity to the active substance or to any of the excipients.
- Active peptic ulceration or active gastro-intestinai (Gl) bleeding.
- Patients who have experienced bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions after taking acetylsalicylic acid or NSAIDs including COX-2 (cyclooxygenase-2) inhibitors.
- Pregnancy and lactation.
- Severe hepatic dysfunction (serum albumin <25 g/l or Child-Pugh score 10).
- Estimated renal creatinine clearance <30 ml/min.
- Children and adolescents under 16 years of age.
- Inflammatory bowel disease.
- Congestive heart failure (NYHA ll-IV).
- Patients with hypertension whose blood pressure is persistently elevated above 140/90 mmHg and has not been adequately controlled.
- Established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease.
Precautions
- Caution is advised with treatment of patients most at risk of developing a gastrointestinal complication with NSAIDs; the elderly, patients using any other NSAID or acetylsalicylic acid concomitantly or patients with a prior history of gastrointestinal disease, such as ulceration and Gl bleeding.
- Patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with Etoricoxib after careful consideration.
- Administration of Etoricoxib may cause a reduction in prostaglandin formation and, secondarily, in renal blood flow, and thereby impair renal function. Monitoring of renal function in such patients should be considered.
- Caution should be exercised in patients with a history of cardiac failure, left ventricular dysfunction, or hypertension and in patients with pre-existing edema from any other reason.
- Any patients with symptoms and/or signs suggesting liver dysfunction, or in whom an abnormalliver function test has occurred, should be monitored. If signs of hepatic insufficiency occur, or if persistently abnormal liver function tests (three times the upper limit of normal) are detected, Etoricoxib should be discontinued.
- Etoricoxib should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.
- Etoricoxib may mask fever and other signs of inflammation. Caution should be exercised when co-administering Etoricoxib with warfarin or other oral anticoagulants.
Side effects
Pregnancy & lactation
Drug interactions
- Oral anticoagulants: In subjects stabilized on chronic warfarin therapy, the administration of Etoricoxib was associated with an increase in prothrombin time.
- Diuretics, ACE inhibitors and Angiotensin II Antagonists: NSAIDs may reduce the effect of diuretics and other antihypertensive drugs.
- Acetylsalicylic Acid: Etoricoxib can be used concomitantly with acetylsalicylic acid at doses used for cardiovascular prophylaxis (low-dose acetylsalicylic acid).
- Ciclosporin and tacrolimus: Although this interaction has not been studied with Etoricoxib, coadministration of ciclosporin or tacrolimus with any NSAID may increase the nephrotoxic effect of ciclosporin or tacrolimus.
- Lithium: NSAIDs decrease lithium renal excretion and therefore increase lithium plasma levels.
More information
Indications
- Osteoarthritis (OA)
- Rheumatoid arthritis (RA)
- Ankylosing spondylitis, and
- The pain and signs of inflammation associated with acute gouty arthritis.
- For the short-term treatment of moderate pain associated with dental surgery.
Dosage
- Osteoarthritis: The recommended dose is 30 mg once daily. In some patients with insufficient relief from symptoms, an increased dose of 60 mg once daily may increase efficacy.
- Rheumatoid arthritis: The recommended dose is 90 mg once daily.
- Ankylosing spondylitis: The recommended dose is 90 mg once daily.
- Acute gouty arthritis: The recommended dose is 120 mg once daily. In clinical trials for acute gouty arthritis, Etoricoxib was given for 8 days.
- Postoperative dental surgery pain: The recommended dose is 90 mg once daily, limited to a maximum of 3 days.
Overdose
Pharmacology
Therapeutic class
Storage
Source: medex.com.bd · Prescribing information (PDF)
Cheaper alternatives
Same generic, strength and form — sorted by price
Etofax
Pharmik Laboratories Ltd.
৳6
Same price
SB-Eto
Sunman-Birdem Pharma Ltd.
৳6.5
৳0.5 more
Temcox
Team Pharmaceuticals Ltd.
৳6.5
৳0.5 more
Kingcox
Medicon Pharmaceuticals Ltd.
৳6.51
৳0.51 more
Aroxia
Ad-din Pharmaceuticals Ltd.
৳6.72
৳0.72 more
Algirex
Ibn Sina Pharmaceuticals Ltd.
৳7
৳1 more
Artorix
Asiatic Laboratories Ltd.
৳7
৳1 more
Cox-E
Popular Pharmaceuticals Ltd.
৳7
৳1 more
CoxTop
Al-Madina Pharmaceuticals Ltd.
৳7
৳1 more
Coxetori
Amulet Pharmaceuticals Ltd.
৳7
৳1 more
Coxsafe
Sharif Pharmaceuticals Ltd.
৳7
৳1 more
Danilo
Healthcare Pharmaceuticals Ltd.
৳7
৳1 more
Eflam
Apex Pharmaceuticals Ltd.
৳7
৳1 more
Eto
Delta Pharma Ltd.
৳7
৳1 more
Etoflam
Jenphar Bangladesh Ltd.
৳7
৳1 more
46 alternatives in total, showing the 15 cheapest